Pharvaris publishes AAE-C1INH disease burden study in Frontiers in Immunology
Go back to Pharvaris publishes AAE-C1INH disease burden study in Frontiers in Immunology| (NASDAQ: PHVS) | Delayed: 37.50 -0.5 (1.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.00 | 52 Week High | $ | |||
| Open | $38.09 | 52 Week Low | $ | |||
| Day High | $38.20 | P/E | N/A | |||
| Day Low | $37.37 | EPS | $ | |||
| Volume | 66,776 | |||||
